10x (TXG) - Stock Quotes

The price trajectory for 10x Genomics, Inc. (TXG) is presented below. The business is based on the creation of advanced Xenium and Chromium systems, which lead the field of genome research. Growth is driven by alliances with oncology centers to identify precision drugs. A high barrier to entry is guaranteed by unique patents and the integration of software with hardware, with the indicator standing at 58.08.

TXG - 10x Price Rate Chart over the range 07/04/2022 - 11/14/2026

10x Genomics Inc (TXG) - metric breakdowns and financial figures

- current price and projected stock value:

Stock Quotes 10x Genomics, Inc.|TXG - Analyst Forecast Prices

- market capitalization indicators:

Market Valuation 10x Genomics Inc|TXG - Business Value

- issuer book value statistics:

Book Value per Share 10x Genomics|TXG - Book Value of Business|Market Capitalization to Book Value Ratio 10xgenomics.com|TXG - Total Business Assets

- business debt structure and liquidity details:

- earnings and market ratios statistics:

TXG - Final Profit|Projected Future Earnings 10x Genomics, Inc.|TXG - Market Cap to Net Income Ratio|Forward P/E Multiple 10x Genomics|TXG - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization 10x Genomics Inc|TXG - Operating profit before amortization|Earnings per share for the last twelve months 10x Genomics|TXG - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months 10xgenomics.com|TXG - Net earnings per share growth this year|Earnings growth forecast for next year 10x Genomics, Inc.

- revenue and sales details:

TXG - Company Gross Revenue|Projected Sales Volume 10x Genomics, Inc.|TXG - Market Cap to Revenue|Price-to-Projected Revenue Ratio 10x Genomics Inc

Comprehensive company analysis:10x Genomics, Inc.

Price reflects the real-time market consensus regarding business valuation, measuring aggregate investor expectations by transforming fundamental risks and prospects into quotes. For 10x Genomics, Inc. (TXG), this metric reflects market confidence in the company's dominance within the spatial biology market. Analyzing the price trajectory allows for the identification of hidden insights or entry points, as price action determines the capital management strategy.

Key competitors